Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

China flag China · Delayed Price · Currency is CNY
12.81
+0.31 (2.48%)
Jul 3, 2026, 3:04 PM CST
Market Cap2.05B -15.2%
Revenue (ttm)260.58M +0.1%
Net Income56.04M +7.6%
EPS0.35 +9.5%
Shares Out 160.00M
PE Ratio36.52
Forward PEn/a
Dividend0.30 (2.34%)
Ex-Dividend DateMay 29, 2026
Volume2,559,500
Open12.24
Previous Close12.50
Day's Range12.24 - 12.93
52-Week Range11.53 - 20.36
Beta0.30
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHE:300519

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers Chinese patent medicines, chemical medicines, and health food in various forms, including tablets, mixtures, granules, syrups, powders, hard capsules, and oral liquids, as well as drinks. Its products are used for the treatment of cardiovascular, trauma, respiratory, digestive, urinary, pediatric, and immunity diseases. The company was incorporated in 1998 and is headquartered ... [Read more]

Sector Healthcare
Founded 1998
Employees 309
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300519
Full Company Profile

Financial Performance

In 2025, SHE:300519's revenue was 265.36 million, a decrease of -0.86% compared to the previous year's 267.66 million. Earnings were 54.21 million, an increase of 7.58%.

Financial Statements